McKesson Stock Price | MCK Stock Quote, News, and History | Markets Insider (2024)

Table of Contents
McKesson NewsMore News Why McKesson (MCK) is a Top Value Stock for the Long-Term Are Investors Undervaluing McKesson (MCK) Right Now? McKesson (MCK) Hits 52-Week High: What's Driving the Stock? Analysts Are Bullish on Top Healthcare Stocks: BeiGene (BGNE), McKesson (MCK) Here's Why McKesson (MCK) is a Strong Value Stock Historical Prices for McKesson McKesson Analyst Data McKesson Analyst Opinions McKesson Estimates* in USD McKesson Insider Activity McKesson Dividend Calendar McKesson Corp. Past Events McKesson Profile Moody’s Daily Credit Risk Score McKesson Shareholder McKesson Management

McKesson NewsMore News

Zacks

Why McKesson (MCK) is a Top Value Stock for the Long-Term

Zacks

Are Investors Undervaluing McKesson (MCK) Right Now?

Zacks

McKesson (MCK) Hits 52-Week High: What's Driving the Stock?

TipRanks

Analysts Are Bullish on Top Healthcare Stocks: BeiGene (BGNE), McKesson (MCK)

Zacks

Here's Why McKesson (MCK) is a Strong Value Stock

Historical Prices for McKesson

McKesson Analyst Data

Total Analysts: 39

Buy Ratings: 30 Neutral Ratings: 9 Sell Ratings: 0

Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}

Price *Price Target

Lowest: 331.00 Median: 441.10 Highest: 620.00

*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

McKesson Analyst Opinions

DateAnalystRatingPrice
03/06/24UBSMaintained Buy$620gut
02/09/24MizuhoMaintained Hold$505neutral
02/08/24Citigroup Corp.Maintained Buy$575gut
01/29/24UBSMaintained Buy$559gut
12/14/23Wells Fargo & CoMaintained Hold$502neutral
11/17/23J.P. MorganMaintained Buy$514gut
11/03/23MizuhoMaintained Hold$450neutral
11/02/23Morgan StanleyMaintained Buy$480gut
10/09/23Argus Research Company Maintained Buy$480gut
08/11/23Credit SuisseMaintained Buy$485gut
08/03/23UBSMaintained Buy$480gut
08/03/23Morgan StanleyMaintained Buy$459gut
07/11/23MizuhoMaintained Hold$427neutral
06/29/23Argus Research Company Maintained Buy$450gut
05/12/23Credit SuisseMaintained Buy$450gut
05/09/23Bank of America Merrill LynchMaintained Buy$470gut
05/09/23Baird Patrick & CoMaintained Buy$475gut
05/09/23MizuhoMaintained Hold$390neutral
05/09/23Barclays CapitalMaintained Buy$420gut
03/31/23Citigroup Corp.Maintained Buy$420gut
02/02/23Morgan StanleyMaintained Buy$426gut
02/02/23Baird Patrick & CoMaintained Buy$450gut
01/31/23UBSMaintained Buy$440gut
01/11/23Baird Patrick & CoMaintained Buy$445gut
01/06/23Morgan StanleyMaintained Buy$420gut
11/14/22MizuhoMaintained Hold$376neutral
11/02/22Barclays CapitalMaintained Hold$415neutral
11/02/22Baird Patrick & CoMaintained Buy$440gut
09/12/22Argus Research Company Maintained Buy$430gut
08/22/22Morgan StanleyMaintained Buy$403gut
08/08/22Credit SuisseMaintained Buy$385gut
08/04/22MizuhoMaintained Hold$345neutral
08/04/22Baird Patrick & CoMaintained Buy$400gut
08/04/22UBSMaintained Buy$400gut
06/07/22Deutsche BankUpgraded to Buy$378gut
05/11/22Credit SuisseMaintained Buy$377gut
05/09/22MizuhoMaintained Hold$331neutral
04/18/22Cowen and Company, LLCMaintained Buy$361gut
04/12/22Morgan StanleyMaintained Buy$370gut

McKesson Estimates* in USD

20242025202620272028
Revenue311,076335,599359,894393,741420,944
Dividend2.392.542.34--
Dividend Yield (in %)0.45 %0.48 %0.44 %--
EPS27.6131.0635.1940.3645.99
P/E Ratio19.3517.2015.1813.2311.61
EBIT4,8975,3155,7776,2766,838
EBITDA5,3235,7616,2086,8057,424
Net Profit3,6413,9194,2694,7645,231
Net Profit Adjusted3,6813,9924,3894,7645,231
Pre-Tax Profit4,6665,0425,4476,1296,707
Net Profit (Adjusted)4,1494,7134,888--
EPS (Non-GAAP) ex. SOE27.6131.0635.1940.3645.99
EPS (GAAP)23.1328.5631.5337.9543.34
Gross Income12,54913,37114,11015,14316,100
Cash Flow from Investing-580-573-584--
Cash Flow from Operations4,0975,2985,5725,5725,930
Cash Flow from Financing-3,456-3,203-3,206-899-911
Cash Flow per Share25.9339.8245.34--
Free Cash Flow3,6324,7985,1024,8685,192
Free Cash Flow per Share25.2637.4848.67--
Book Value per Share-15.43-5.6311.75--
Net Debt3,4762,289-42-1,365-
Research & Development Exp.-----
Capital Expenditure358412420103110
Selling, General & Admin. Exp.7,9838,3218,71510,27810,936
Shareholder’s Equity-1,918-1,0735202,8675,094
Total Assets67,96373,06777,70085,16591,441
Previous QuarterCurrent QuarterNext QuarterCurrent Year
ending 03/31/24		Next Year
ending 03/31/25
Earnings Estimates
No. of Analysts---1616
Average Estimate---27.611 USD31.063 USD
Year Ago---25.940 USD27.611 USD
Publish Date-----
Revenue Estimates
No. of Analysts---1514
Average Estimate---311,076 USD335,599 USD
Year Ago---276,711 USD311,076 USD
Publish Date-----

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

McKesson Insider Activity

NameDateshares tradedshares heldPricetype (sell/buy)option
Tyler Brian Scott03/14/20243,473.0043,445.00524.55Sell No
Tyler Brian Scott03/14/20243,473.0046,918.00159.00Buy No
Rutledge Napoleon B JR03/03/2024190.00887.00529.99Sell No
Rutledge Napoleon B JR02/29/2024183.001,077.00525.88Sell No
Rutledge Napoleon B JR02/29/202461.00647.00525.88Sell No
Rutledge Napoleon B JR02/29/2024613.001,260.00n/aBuy No
Rutledge Napoleon B JR02/29/2024172.00708.00n/aBuy No
Smith LeAnn B02/12/2024186.001,511.00496.00Sell No
Tyler Brian Scott01/02/20243,908.0043,445.00480.00Sell No
Tyler Brian Scott01/02/202410,118.0043,445.00480.00Sell No
Tyler Brian Scott01/02/20243,908.0047,353.00123.99Buy No
Tyler Brian Scott01/02/202410,118.0053,563.00144.43Buy No
Tyler Brian Scott11/06/2023465.0043,445.00460.77Sell No
Tyler Brian Scott11/06/2023659.0043,910.00459.59Sell No
Tyler Brian Scott11/06/20233,042.0044,569.00458.72Sell No
Tyler Brian Scott11/06/202310,667.0047,611.00457.63Sell No
Tyler Brian Scott11/06/20237,371.0058,278.00456.88Sell No
Tyler Brian Scott11/06/20231,759.0065,649.00455.67Sell No
Smith LeAnn B11/02/2023660.001,325.00461.26Sell No
Tyler Brian Scott10/11/20232,932.0067,408.00460.00Sell No
Tyler Brian Scott10/11/20237,589.0067,408.00460.00Sell No
Tyler Brian Scott10/11/20232,932.0070,340.00123.99Buy No
Tyler Brian Scott10/11/20237,589.0074,997.00144.43Buy No
Tyler Brian Scott10/08/20233,471.0067,408.00450.00Sell No
Tyler Brian Scott10/08/20233,471.0070,879.00159.00Buy No

McKesson Dividend Calendar

DateNameDividend*yieldCurrency
2023McKesson Corp.2.090.59USD
2022McKesson Corp.1.830.60USD
2021McKesson Corp.1.670.86USD
2020McKesson Corp.1.621.20USD
2019McKesson Corp.1.511.29USD
2018McKesson Corp.1.300.92USD
2017McKesson Corp.1.120.76USD
2016McKesson Corp.1.080.69USD
2015McKesson Corp.0.960.42USD
2014McKesson Corp.0.920.52USD
2013McKesson Corp.0.800.73USD
2013McKesson Corp.0.800.74USD
2012McKesson Corp.0.800.91USD
2011McKesson Corp.0.720.91USD
2010McKesson Corp.0.480.79USD
2010McKesson Corp.0.480.73USD
2009McKesson Corp.0.481.33USD
2009McKesson Corp.0.481.37USD
2008McKesson Corp.0.240.46USD
2007McKesson Corp.0.240.41USD
2006McKesson Corp.0.240.46USD
2005McKesson Corp.0.240.64USD
2004McKesson Corp.0.240.80USD
2003McKesson Corp.0.240.96USD
2002McKesson Corp.0.240.64USD
2001McKesson Corp.0.240.90USD
2000McKesson Corp.0.241.14USD
1999McKesson Corp.0.440.67USD

*Yield of the Respective Date

McKesson Corp. Past Events

EventActual EPSInfoDate
Earnings Report 6.230 USDQ3 2024 Earnings Release02/07/2024
Press Conference --02/07/2024
Press Conference --11/01/2023
Press Conference --08/02/2023
Press Conference --05/08/2023

McKesson Profile

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U. S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U. S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs.

Moody’s Daily Credit Risk Score

Risk

  • Low
  • Medium
  • High

7

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’sbalance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of creditrisk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes intoaccount day-to-day movements in market value compared to a company’s liability structure.

McKesson Shareholder

Ownerin %
Freefloat99.94
The Vanguard Group, Inc.9.24
Vanguard Group, Inc. (Subfiler)8.80
State Street Corp.4.81
Massachusetts Financial Services Co.3.82
Vanguard Total Stock Market ETF3.17
BlackRock Fund Advisors2.93
JPMorgan Investment Management, Inc.2.57
Vanguard 500 Index Fund2.53
BlackRock Institutional Trust Co. NA2.39
MFS Value Fund2.10
Geode Capital Management LLC1.93
Berkshire Hathaway, Inc.1.74
Viking Global Investors LP1.70
Norges Bank (13F)1.68

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

McKesson Management

NameJob
Napoleon B. RutledgeChief Accounting Officer, Senior VP & Controller
Brian Scott TylerChief Executive Officer & Director
Britt J. VitaloneChief Financial Officer & Executive Vice President
LeAnn B. SmithChief Human Resources Officer & Executive VP
Michele M. LauChief Legal Officer, EVP & General Counsel
Tom RodgersChief Strategy & Business Development Officer, EVP
Francisco FragaChief Technology & Information Officer, EVP
Victor SolomonDirector-Enterprise Sales
Jennifer M. CarterDirector-Sales Process & Compensation
Donald R. KnaussIndependent Chairman
Bradley E. LermanIndependent Director
Dominic J. CarusoIndependent Director
James H. HintonIndependent Director
Kathleen Wilson-ThompsonIndependent Director
Kevin M. OzanIndependent Director
Linda Provie MantiaIndependent Director
Maria MartinezIndependent Director
Richard H. CarmonaIndependent Director
Susan R. SalkaIndependent Director
Webster Roy DunbarIndependent Director
Rachel RodriguezInvestor Relations Contact
Faith MyersPrivacy Officer & Vice President
Saralisa C. BrauSecretary
Rashmi KumarSenior Vice President & CIO-US Pharmaceutical
Kevin W. EmersonSenior Vice President-Finance Operations
Neisha Strambler-ButlerSenior Vice President-Total Rewards
Elizabeth MusicoVice President-Human Resources
Wanda Jackson-DavisVice President-Sourcing & Procurement
McKesson Stock Price | MCK Stock Quote, News, and History | Markets Insider (2024)
Top Articles
6 Common Reasons Your Investments May Trigger an IRS Audit | Bankrate
Why Do Companies Offer Stock Options?
Craigslist Arlington
Garudan 2024 Full Tamil Movie Online Watch in HD 720p DVDRip
Purdue Rivals Forum
Total Eclipse of the Heart - Chapter 24 - HyphenL, Takemikazuchi, thesaucenart
xDrive: Alle Fakten rund um das intelligente Allradsystem von BMW
Acing Your sweetgreen Interview: The Top 15 Questions and Expert Tips
Where to Eat - A guide to the Best Restaurants in Tel Aviv — discover tel aviv
Best Fish Restaurants in Tel Aviv
Labcorpbeacon Login
The Expendables 4: Trailer, Release Date & Everything We Know
Latest Posts
Average pension value by type in Russia 2021 | Statista
What Does Goodwill Mean in Accounting? The Essential Features
Article information

Author: Francesca Jacobs Ret

Last Updated:

Views: 5982

Rating: 4.8 / 5 (68 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Francesca Jacobs Ret

Birthday: 1996-12-09

Address: Apt. 141 1406 Mitch Summit, New Teganshire, UT 82655-0699

Phone: +2296092334654

Job: Technology Architect

Hobby: Snowboarding, Scouting, Foreign language learning, Dowsing, Baton twirling, Sculpting, Cabaret

Introduction: My name is Francesca Jacobs Ret, I am a innocent, super, beautiful, charming, lucky, gentle, clever person who loves writing and wants to share my knowledge and understanding with you.